UiPath’s PATH stock rebound reflects rising confidence in its strengthening fundamentals and long-term AI automation prospects, with investors increasingly viewing current valuations as appealing ...

Business automation software company UiPath Inc. beat expectations for its third-quarter financial results today and followed up with strong guidance for the current quarter. The company reported ...

UiPath Inc. (NYSE: PATH) stock jumped in Wednesday's extended trading after the company released its third quarter earnings report, beating expectations on the top and bottom lines. Here's a look at ...

Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...

A new proof-of-concept attack shows that malicious Model Context Protocol servers can inject JavaScript into Cursor’s browser — and potentially leverage the IDE’s privileges to perform system tasks.

UiPath announced a number of new collaborations and products at its Fusion conference. Time magazine named its agentic automation one of the best inventions of the year. Some of its peers are seeing ...

The U.S. Federal Reserve (Fed) pumped $29.4 billion into the banking system on Friday, sparking optimism on crypto social media. While the move aimed at easing liquidity concerns and is supportive of ...

UiPath is positioning itself as the bridge connecting humans, systems, and AI. The company has narrowed losses and is approaching profitability. The long-term growth runway is large. 10 stocks we like ...

Note that some links may require registration or subscription. The practice of "bluetoothing," when users inject the blood of already intoxicated individuals, is contributing to global HIV spikes.

UiPath is making significant strides in Agentic Automation, partnering with Deloitte and HCLTech to advance AI-driven solutions. UiPath's Q2 results show robust revenue and profitability, but ARR ...